Filing Details
- Accession Number:
- 0000711377-16-000086
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-10-03 18:29:33
- Reporting Period:
- 2016-09-29
- Filing Date:
- 2016-10-03
- Accepted Time:
- 2016-10-03 18:29:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1168789 | L James Herbert | Neogen Corp 620 Lesher Place Lansing MI 48912 | Chairman & Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-09-29 | 2,481 | $23.07 | 886,045 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-09-29 | 12,167 | $23.07 | 898,212 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-09-30 | 3,000 | $54.75 | 895,212 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-09-30 | 6,000 | $55.26 | 889,212 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-10-03 | 3,000 | $55.60 | 886,212 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock (Right to Buy) | Disposition | 2016-09-29 | 16,501 | $0.00 | 16,501 | $23.07 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 280,001 | 2016-09-29 | No | 4 | M | Direct |
Footnotes
- Options were granted on 9/29/2011, have five year lives, and vest 20% per year in equal annual installments on each of the first five anniversary dates of the grant
- The plan allows for the exchange of outstanding options for currently valued shares in an amount equal to the optionee's equity in the options held
Billionaire Hedge Funds
